Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats

Journal of Clinical Neuroscience

Volumn 14, Issue 2, 2007, Pages 138-142

  Beril Gok, H ^a   Solaroglu, Ihsan ^a   Okutan, Ozerk ^b   Cimen, Behzat ^c   Kaptanoglu, Erkan ^b   Palaoglu, Selcuk ^d  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Beta blocker; Methylprednisolone; Metoprolol; Myeloperoxidase; Spinal cord injury

Indexed keywords

BIOLOGICAL MARKER; METHYLPREDNISOLONE; METOPROLOL; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; INHIBITION KINETICS; LAMINECTOMY; LEUKOCYTE ACTIVATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPINAL CORD; SPINAL CORD INJURY; TISSUE; TISSUE INJURY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS; FEMALE; METHYLPREDNISOLONE; METOPROLOL; NEURONS; NEUROPROTECTIVE AGENTS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEROXIDASE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SPINAL CORD INJURIES;

EID: 33845201421     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.10.016     Document Type: Article

References (46)

1. Balentine J.D. Pathology of experimental spinal cord trauma II. Ultrastructure of axons and myelin. Lab Invest 39 (1978) 99-107
2. Ducker T.B., Kindt G.W., and Kempf L.G. Pathological findings in acute experimental spinal cord trauma. J Neurosurg 35 (1971) 700-708
3. Osterholm J.L., and Mathews G.J. Altered norepinephrine metabolism following spinal cord injury: Part 1: relationship to hemorrhagic necrosis. J Neurosurg 36 (1972) 386-394
4. Means E.D., and Anderson D.K. Neurophagia by leucocytes in experimental spinal cord injury. J Neuropatholog Exp Neurol 42 (1983) 707-719
5. Taoka Y., Okajima K., Uchiba M., et al. Role of neutrophils in spinal cord injury in rats. Neuroscience 79 (1997) 1177-1182
6. Tator C.H. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 42 (1998) 696-708
7. Kaptanoglu E., Tuncel M., Palaoglu S., et al. Comparison effect of melatonin and methylprednisolone in experimental spinal cord injury. J Neurosurg 93 (2000) 77-84
8. Kaptanoglu E., Solaroglu I., Okutan O., et al. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effects on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 27 (2004) 113-120
9. Kaptanoglu E., Beskonakli E., Solaroglu I., et al. Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev 26 (2003) 283-287
10. Kaptanoglu E., Caner H.H., Surucu S.H., et al. Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury. J Neurosurg 91 (1999) 200-204
11. Ildan F., Polat S., Oner A., et al. Effects of naloxone on sodium- and potassium-associated and magnesium dependent adenosine-5'-triphosphate activity and lipid peroxidation and early ultrastructural findings after experimental spinal cord injury. Neurosurgery 36 (1995) 797-805
12. Xu J., Hsu C., Liu T., et al. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord. J Neurochemistry 55 (1990) 907-912
13. Hamada Y., Ikata T., Katoh S., et al. Involvement of an intracellular adhesion molecule-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats. J Neurochem 32 (1996) 192-194
14. Beta-blocker Heart Attack Trial Research Group. A randomised trial of propranolol in patients with acute myocardial infarction-1: Mortality results. JAMA 1982;247:1707-1714.
15. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (AMI): A randomised placebo-controlled international trial. Eur Heart J 1985;6:199-226.
16. Mak I.T., and Weglicki W.B. Protection by beta-blocking agents against free radical mediated sarcolemmal lipid peroxidation. Circ Res 1 (1988) 262-266
17. Gao F., Chen J., Lopez B.L., et al. Comparison of bisoprolol and carvedilol cardioprotection in rabbit ischemia and reperfusion model. Eur J Pharmacol 406 (2000) 109-116
18. Toleikis P.M., and Tomlinson C.W. Myocardial function preservation during ischemia: influence of beta-blocking agents. Mol Cell Biochem 176 (1997) 205-210
19. Yamagata K., Ichinose S., and Tagami M. Amlodipine and carvedilol prevents cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Hypertens Res 27 (2004) 271-282
20. Wood J.P., Schmidt K.G., Melena J., et al. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectant: comparison with betaxolol. Exp Eye Res 76 (2003) 505-516
21. Osborne N.N., Ugarte M., Chao M., et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 43 (1999) 102-128
22. Lysko P.G., Lysko K.A., Yue T.L., et al. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured cerebellar neurons and in gerbil global brain ischemia. Stroke 23 (1992) 1630-1635
23. Arai K., Wood J.P., and Osborne N.N. Beta-adrenergic receptor agonist and antagonist counteract LPS-induced neuronal death in retinal cultures by different mechanisms. Brain Res 985 (2003) 176-186
24. Nakazawa T., Tomita H., Yamaguchi K., et al. Neuroprotective effect of nipradiol on axotomized rat retinal ganglion cells. Curr Eye Res 24 (2002) 114-122
25. Kashiwagi K., Iizuka Y., and Tsukahara S. Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells. J Glaucoma 11 (2002) 231-238
26. Hamann G., Haass A., and Schimrigk K. Beta-blockade in acute aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 121 (1993) 119-122
27. Savitz S.I., Erhandt J.A., Anthony I.V., et al. The novel beta-blocker, carvedilol provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab 20 (2000) 1197-1204
28. Yue T.L., Lysko P.G., Barone F.C., et al. Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection. Ann NY Acad Sci 738 (1994) 230-242
29. Ilhan A., Yilmaz N.R., Armutcu F., et al. The protective effect of nebivolol on ischemia/reperfusion injury in rabbit spinal cord. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 1153-1160
30. Allen A.R. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. JAMA 256 (1911) 878-880
31. Springer T. Adhesion receptors of the immune system. Nature 346 (1990) 425-434
32. Fujita H., Morita I., and Murota S. A possible mechanism for vascular endothelial cell injury elicited by activated leukocytes: a significant involvement of adhesive molecules, CD11/ CD8 and ICAM-1. Arch Biochem Biophysiol 309 (1994) 62-69
33. Hallenbeck J.M., Dutka A.J., Tanishima T., et al. Polymorphonuclear leukocyte accumulation in brain region with low blood flow during the early postischemic period. Stroke 17 (1986) 246-253
34. Rainer T.H., Law N., and Cocks R.A. Adrenaline upregulates monocyte L-selectin in vitro. Resuscitation 43 (1999) 47-55
35. Yue T.L., Wang X., Gu J.L., et al. Carvedilol prevents low-density lipoprotein enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation. Eur J Pharmacol 294 (1995) 585-591
36. Rehman J., Mills P.J., Carter S.M., et al. Dynamic exercise leads to an increase in circulating ICAM-1: further evidence for adrenergic modulation of cell adhesion. Brain Behav Immun 11 (1997) 343-351
37. Wada S., Yone K., Ishidou Y., et al. Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist. J Neurosurg 91 Suppl.1 (1999) 98-104
38. Young W. Role of calcium in central nervous system trauma. J Neurotrauma 9 Suppl.1 (1992) 9-25
39. Rossi M.A., Curzio M., Di M., et al. Experimental studies on the mechanism of action of 4-hydroxy-2,3-trans-noneal, a lipid peroxidation product displaying chemotactic activity toward rat neutrophils. Cell Biochem Funct 9 (1991) 163-170
40. Suzuki Y., Tanaka M., Sohmiya M., et al. Antioxidant properties of carvedilol: inhibition of lipid peroxidation, protein oxidation and superoxide generation. Neurol Res 25 (2003) 749-753
41. Melena J., and Osborne N.N. Metipranolol attenuates lipid peroxidation in rat brain: a comparative study with other antiglaucoma drugs. Graefes Arch Clin Exp Ophthalmol 241 (2003) 827-833
42. Dunzendorfer S., and Wiedermann C.J. Modulation of neutrophil migration and superoxide anion release by metoprolol. J Mol Cell Cardiol 32 (2000) 915-924
43. Djanai A., Kaneider N., Meierhofer C., et al. Inhibition of neutrophil migration and oxygen free radical release by metipranolol and timolol. Pharmacology 68 (2003) 198-203
44. Tecoma E.S., Motulsky H.J., Traynor A.E., et al. Transient catecholamine modulation of neutrophil activation: kinetic and intracellular aspects of isoproterenol action. J Leukoc Biol 40 (1986) 629-644
45. Galant S.P., and Allred S. Binding and functional characteristics of beta adrenergic receptors in the intact neutrophil. J Lab Clin Med 98 (1981) 227-237
46. Niggli V. Signaling to migration in neutrophils: importance of localized pathways. Int J Biochem Cell Biol 35 (2003) 1619-1638